Angiotensin 2 Type 1 Receptor Antagonists [MoA]
Semantic Scholar uses AI to extract papers important to this topic.
A new treatment for heart failure (HF) combining angiotensin 2 type 1 receptor blockade with inhibition of the widespread… Expand This editorial refers to ‘Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies’, by S.J… Expand The metabolic syndrome affects 30% of the US population with increasing prevalence. In this paper, we explore the relationship… Expand BackgroundBoth angiotensin II type I receptor blockers (ARBs) and calcium channel blockers (CCBs) are widely used… Expand The aim of the present work was to review published studies investigating the dose‐related efficacy on blood pressure (BP) of… Expand Recent large clinical trials have shown that angiotensin II type I receptor blockers (ARBs) reduce cardiovascular morbidity and… Expand Anemia is one of the most serious complications in patients on dialysis. Erythropoietin improves the anemia. However… Expand OBJECTIVE
Angiotensin-converting enzyme (ACE) inhibitor and angiotensin II type I receptor blockers (ARB) prevent cardiac… Expand Have the theoretical advantages of the angiotensin II receptor blockers become reality for the treatment of chronic heart failure… Expand Angiotensin II type I receptor antagonists (ARAs) have been tested in two large randomized trials, Evaluation of Losartan in the… Expand